IGHE and neoplasm: IgE antibodies directed against tumour‐associated antigens (TAA) could mediate the cell‐to‐cell association between tumour and effector cells, resulting in antibody‐dependent cellular toxicity (ADCC) and antibody‐dependent cellular phagocytosis (ADCP).